Expression of programmed death ligand-1 in the urothelium in nonbacterial chronic cystitis and bladder cancer

被引：0
|
作者：
Kosova, I [1 ]
Barsegian, V [1 ]
Sinyakova, L. [1 ]
Gundorova, L. [2 ]
Kolbasov, D. [3 ]
机构：
[1] Russian Med Acad Continuous Profess Educ, Dept Urol & Surg Androl, Moscow, Russia
[2] Demikhov City Clin Hosp, Dept Pathol Anat, Moscow, Russia
[3] Demikhov City Clin Hosp, Dept Urol, Moscow, Russia
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0726
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    [J]. 慢性疾病与转化医学(英文), 2019, 5 (03) : 170 - 177
  • [2] Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer
    Riobello, Cristina
    Vivanco, Blanca
    Reda, Sara
    Lopez-Hernandez, Alejandro
    Garcia-Inclan, Cristina
    Potes-Ares, Sira
    Cabal, Virginia N.
    Lopez, Fernando
    Luis Llorente, Jose
    Hermsen, Mario A.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (04): : 818 - 827
  • [3] PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer
    Kosova, Inga
    Barsegian, Vagan
    Gundorova, Lyudmila
    Kolbasov, Dmitriy
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2024, 35 (05) : 1069 - 1075
  • [4] Expression of programmed death ligand-1 on bladder tissues is detected in a clinically and histologically well-defined interstitial cystitis cohort
    Chen, Yuke
    Yu, Wei
    Yang, Yang
    Xiao, Yunxiang
    Cui, Yun
    Duan, Jihong
    He, Qun
    Jin, Jie
    Wu, Shiliang
    [J]. NEUROUROLOGY AND URODYNAMICS, 2018, 37 (04) : 1396 - 1404
  • [5] Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer
    Sun, Anran
    Luo, Yu
    Xiao, Wen
    Zhu, Zhipeng
    Yan, Hongyu
    Miao, Chaohao
    Zhang, Wenzhao
    Bai, Peide
    Liu, Chenfeng
    Yang, Dianqiang
    Shao, Zhiqiang
    Song, Jing
    Wu, Zhun
    Chen, Bin
    Xing, Jinchun
    Wang, Tao
    [J]. LABORATORY INVESTIGATION, 2023, 103 (07)
  • [6] Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select
    Drake, Charles G.
    Bivalacqua, Trinity J.
    Hahn, Noah M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3115 - +
  • [7] Chemotherapy induces alteration of programmed death ligand-1 expression in gastric cancer
    Yamashita, Kohei
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Eto, Kojiro
    Koga, Yuki
    Kiyozumi, Yuki
    Baba, Yoshifumi
    Yoshida, Naoya
    Baba, Hideo
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] Immunohistochemical Expression of Programmed Death Ligand-1 in Tumour Milieu of Oral Cancer
    Khan, Moomal Aslam
    Syed, Serajuddaula
    Wahab, Noor Ui
    Butt, Saima Akram
    [J]. ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2019, 24 (04): : 187 - 194
  • [9] Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
    Kim, Ji-Hyun
    Kim, Shinn-Young
    Shin, Eun-Young
    Jung, Ji-Han
    Choi, Hyun-Joo
    Jun, Kyong-Hwa
    [J]. ONCOLOGY LETTERS, 2019, 18 (03) : 2661 - 2669
  • [10] Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
    Ohigashi, Y
    Sho, M
    Yamada, Y
    Tsurui, Y
    Hamada, K
    Ikeda, N
    Mizuno, T
    Yoriki, R
    Kashizuka, H
    Yane, K
    Tsushima, F
    Otsuki, N
    Yagita, H
    Azuma, M
    Nakajima, Y
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2947 - 2953
12345